US President Joe Biden tested negative for COVID-19 on Saturday but will continue to self-isolate at the White House until a second negative test, his doctor said.
Dr Kevin O’Connor wrote in his latest daily update that the President, “with great caution”, will adhere to the “strict isolation measures” in place since his “rebound” infection was detected on the 30th July, pending follow-up. negative result.
Biden, 79, caught the virus a second time three days after coming out of isolation from his initial bout with COVID-19, reported July 21. There have been rare documented cases of rebound among a small minority of those who love Biden, was prescribed the antiviral drug Paxlovid, which has been shown to reduce the risk of serious illness and death from the virus. in those most at risk.
O’Connor wrote that Biden “continues to feel great.”
Biden’s trip has been put on hold pending a negative test. He plans to visit Kentucky on Monday to view catastrophic flood damage and meet with families.
RELATED: Biden tests positive for COVID-19, returns to isolation
Biden was “doing very well,” White House press secretary Karine Jean-Pierre said on Saturday when asked about his health during his appearance in Las Vegas at a joint conference of the National Association of black journalists and the National Association of Hispanic Journalists. She said that when she talks to the president, he tells her to “tell people that I work more than eight hours a day.”
During his first go-around with the virus, Biden’s main symptoms were a runny nose, fatigue and a wet cough, his doctor said at the time. During his rebound case, O’Connor said only Biden’s cough returned and “almost completely resolved” on Friday.
Regulators are still studying the prevalence and virulence of rebound cases, but the Centers for Disease Control and Prevention in May warned doctors that it had been reported to occur within two days to eight days after an initial test negative for the virus.
“The limited information currently available from case reports suggests that people treated with Paxlovid who experience COVID-19 rebound have had mild disease; there are no reports of serious illness,” the agency said at the time.